Moreover, there was negative correlation between SNHG1 levels and EFS (HR = 1.58, 95% CI = 1.06–2.35) in neuroblastoma, RFS (HR = 2.15, 95% CI = 1.23–3.77) in hepatocellular carcinoma, PFS (HR = 2.75, 95% CI = 1.70–4.46) in colorectal cancer, and DFS (HR = 1.93, 95% CI = 1.10–3.40) in laryngeal squamous cell carcinoma. The gene discussed is SNHG1; the disease is neuroblastoma.